News & Updates
Filter by Specialty:
Early transition to oral antimicrobials prevents treatment failure in children with SAB, AHO
Children with Staphylococcus aureus bacteraemia (SAB), a common complication of acute hematogenous osteomyelitis (AHO), are vulnerable to a wide range of illnesses, suggests a study. Thus, classifying its severity may aid in treatment decision-making.
Early transition to oral antimicrobials prevents treatment failure in children with SAB, AHO
27 Aug 2022Trial of two tenofovir-containing regimens for HIV/HBV co-infection: Insights from ALLIANCE
The triplet combination of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is as good as dolutegravir + emtricitabine/tenofovir disoproxil fumarate (DTG+F/TDF) in terms of efficacy for HIV control but results in better hepatitis B virus (HBV) outcomes in patients with HIV/HBV co-infection, according to results of the phase III ALLIANCE trial presented at IAS 2022.
Trial of two tenofovir-containing regimens for HIV/HBV co-infection: Insights from ALLIANCE
24 Aug 2022Measuring patient-based changes in temperature could improve COVID-19 detection in nursing homes
Among nursing home residents, rather than using a one-size-fits-all threshold temperature, looking at individual changes in body temperature and temperature variability, could lead to better prediction of COVID-19 infection, a recent study has found.
Measuring patient-based changes in temperature could improve COVID-19 detection in nursing homes
24 Aug 2022COVID-19 lockdowns reduce exercise in CIED patients
Patients with cardiac implantable electronic devices (CIED) see lower levels of physical activity during the COVID-19 pandemic, especially during a period of lockdown, according to a recent Germany study. While younger patients resume exercise with the easing of restrictions, older patients tend to remain inactive.
COVID-19 lockdowns reduce exercise in CIED patients
23 Aug 2022Which factors predict relapse after antiviral therapy cessation in paediatric CHB?
Nearly one in three children with chronic hepatitis B (CHB) who discontinued their antiviral treatment has relapsed, a study has shown.